HeartShare recently received notice of award from the NHLBI for our X01 proposal, which provides funding to conduct omics analyses for ~3000 biospecimens from 14 different studies. The overall objective for the X01 is to create an innovative and comprehensive HeartShare TOPMed multi-omics resource to facilitate identification of novel HFpEF subtypes and treatment targets.